| abstract |
This invention provides compounds of formula I n n n and pharmaceutically acceptable salts and solvates thereof, characterized that the compound is in particulate form and having a specific size range. n The present invention further provides pharmaceutical compositions containing or formulated using compounds of formula I, and the use of such compounds for alleviating human pathologies, including osteoporosis, serum lipid lowering, and breast cancer. |